PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Upcoming Events

SLAS
Bio IT
PEGS Boston
ELRIG Drug Discovery USA
Biotechnology Show 13.02.26
PFS & Injectable drug devices west coast
PFS & Injectable Drug Devices East Cost

Advertisement

A&M Stabtest April 26
Scientific Lab Show
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
QMB Innovation Centre
Polypure hompage
DDL 2026
Volume 8 Issue 3

Beyond Small Molecules: How Advances in 3D Modelling Are Opening New Frontiers in Macrocyclic Drug Discovery

While traditional small molecules excel at targeting buried active sites, they often struggle with flatter protein surface interactions. Macrocyclic compounds of...
Continue Reading →
Volume 8 Issue 3

Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates

Antibody-drug conjugates (ADCs) are one of the most rapidly expanding forms of oncology treatment and therapeutic successes have led to an unprecedented expansio...
Continue Reading →
Volume 8 Issue 3

Lipid Nanoparticles (LNPs) for Nucleic Acid Delivery 

Lipid nanoparticles (LNPs) are one of the most prominent tools for nucleic acid delivery. Their versatility allows the encapsulation of different cargos (siRNA, ...
Continue Reading →
Volume 8 Issue 3

Accelerating Cell Line Selection with Integrated Analytical Strategies

Cell line development is a critical determinant of success in biologics manufacturing. It lays the foundation for product yield, quality and long-term process st...
Continue Reading →
Volume 8 Issue 3

Leveraging Strategic Partnerships to Enhance Flexibility in Facility Design and Bioprocesses

Flexibility is an operational imperative in today’s fast-evolving biopharmaceutical industry. Contract development and manufacturing organisations (CDMOs), as in...
Continue Reading →
Volume 8 Issue 3

Turning the Temperature Up on Cold Chain Logistics

As biopharma therapies become more sensitive, costly and complex, traditional compliance frameworks are no longer enough. Real-time visibility and IoT innovation...
Continue Reading →
Volume 8 Issue 3

Developing Endotoxin Limits, Risk Assessment and In-process Testing for CGT Products

Cell & Gene Therapy (CGT) products face a unique challenge in the required pyrogen testing for injectable wares. Since this test was written for conventional...
Continue Reading →
Volume 8 Issue 2

Why Renting Product Inspection Systems Makes Strategic Sense for Pharma Manufacturers

Production lines don’t pause for procurement. When pharmaceutical manufacturers face a sudden spike in demand, new quality control requirements or equipment failure,...
Continue Reading →
Volume 8 Issue 2

The Importance of Mass Spectrometry 

Mass spectrometry (MS) has long been a cornerstone analytical technique in the pharmaceutical and biopharmaceutical industries. Its ability to provide detailed molec...
Continue Reading →
Volume 8 Issue 2

Plan, Lead, Deliver: A Framework for Regulatory Writing Success 

Q: Is your team simply writing a dossier, or are they following a clear strategy?A: The most effective teams do both, but strategy should come first. Preparing a sub...
Continue Reading →
The Bridge 28.01
Newcells 3 June 2024, 15:12
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Taconic Biosciences – 29.04.25
Steribar – 12.05.2025
Crown Bioscience 08.09.2025
Aseptic Tech
PharmExcel